Triazavirin
- Generic Name
- Triazavirin
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C5H4N6O3S
- CAS Number
- 123606-06-4
- Unique Ingredient Identifier
- F2HTG1MH2D
- Background
Triazavirin is a guanine nucleotide analog antiviral originally developed in Russia that has shown efficacy against influenza A and B, including the H5N1 strain. It appears that Triazavirin has shown promise in reducing influenza disease severity and associated complications. Given the similarities between SARS-CoV-2 and H5N1, health officials are investigating Triazavirin as an option to combat SARS-CoV-2, the coronavirus responsible for COVID-19.
- Indication
Triazavirin was developed in Russia as a potential treatment of Influenza A and B infections.
- Associated Conditions
- -
- Associated Therapies
- -
No trials found
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath